More and more evidence keeps pointing to clonal hematopoiesis (CHIP) as a risk factor for CVD and other age-related diseases like cancer.
Clonal hematopoiesis of indeterminate potential, or CHIP, is a common aging-related phenomenon in which hematopoietic stem cells (produced by the bone marrow) or other early blood cell progenitor cells contribute to the formation of a genetically distinct mutated subpopulation of blood cells. This mutated subpopulation of blood cells is pathological and contributes to the formation of disease.
If we live long enough, all of us will ultimately develop CHIP. It appears to be an inevitable consequence of the aging process itself, except in rare cases. This is one of the mechanisms by which aging itself causes diseases like CVD and cancer.
It can also be caused earlier in life by exposure to certain mutagenic agents, such as cytotoxic chemotherapy drugs for cancer treatment.


